


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:55Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405121" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405121</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ejnmmires</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">EJNMMI Res</journal-id><journal-id journal-id-type="iso-abbrev">EJNMMI Res</journal-id><journal-id journal-id-type="pmc-domain-id">1625</journal-id><journal-id journal-id-type="pmc-domain">ejnmmires</journal-id><journal-title-group><journal-title>EJNMMI Research</journal-title></journal-title-group><issn pub-type="epub">2191-219X</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405121</article-id><article-id pub-id-type="pmcid-ver">PMC12405121.1</article-id><article-id pub-id-type="pmcaid">12405121</article-id><article-id pub-id-type="pmcaiid">12405121</article-id><article-id pub-id-type="pmid">40892317</article-id><article-id pub-id-type="doi">10.1186/s13550-025-01311-w</article-id><article-id pub-id-type="publisher-id">1311</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress <sup>11</sup>C-acetate PET</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="SG">Sang-Geon</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0692-5640</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="HY">Hyung Yoon</given-names></name><address><email>medoc7@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="KS">Ki Seong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="J">Jahae</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moon</surname><given-names initials="JB">Jang Bae</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="N">Nuri</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="H">Hyukjin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="JY">Jae Yeong</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yoon</surname><given-names initials="HJ">Hyun Ju</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ahn</surname><given-names initials="Y">Youngkeun</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Doh</surname><given-names initials="JH">Joon-Hyung</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shin</surname><given-names initials="ES">Eun-Seok</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="KH">Kye Hun</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="HC">Ho-Chun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f200z37</institution-id><institution-id institution-id-type="GRID">grid.411597.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2471</institution-id><institution>Department of Nuclear Medicine, </institution><institution>Chonnam National University Hospital, </institution></institution-wrap>Gwangju, Republic of Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f200z37</institution-id><institution-id institution-id-type="GRID">grid.411597.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 2471</institution-id><institution>Department of Cardiovascular Medicine, </institution><institution>Chonnam National University Hospital, </institution></institution-wrap>Gwangju, Republic of Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01zx5ww52</institution-id><institution-id institution-id-type="GRID">grid.411633.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0371 8173</institution-id><institution>Division of Cardiology, College of Medicine, </institution><institution>Inje University Ilsan-Paik Hospital, </institution></institution-wrap>Goyang, Korea </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03sab2a45</institution-id><institution-id institution-id-type="GRID">grid.412830.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 7248</institution-id><institution>Department of Cardiology, </institution><institution>Ulsan University Hospital, University of Ulsan College of Medicine, </institution></institution-wrap>Ulsan, Republic of Korea </aff><aff id="Aff5"><label>5</label>Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Incheon Sejong Hospital, Incheon, Republic of Korea </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">479053</issue-id><elocation-id>116</elocation-id><history><date date-type="received"><day>3</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="13550_2025_Article_1311.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1"><sup>11</sup>C-acetate positron emission tomography (PET) enables simultaneous quantification of myocardial blood flow (MBF) and oxidative metabolism; however, sex-specific normative data under vasodilator stress remain insufficiently defined. We aimed to characterize these parameters in healthy individuals.</p></sec><sec><title>Results</title><p id="Par2">Eighteen healthy individuals (9 males and 9 females, age/sex-matched; median age 43 years [range 34&#8211;65]) with normal echocardiography and no underlying cardiovascular disease underwent one-day rest-stress dynamic <sup>11</sup>C-acetate PET with adenosine. Median stress MBF was 2.73 (2.24&#8211;3.11) mL/min/g and rest MBF 0.99 (0.82&#8211;1.14) mL/min/g. Stress kmono was 0.074 (0.063&#8211;0.082)/min, and rest kmono was 0.061 (0.050&#8211;0.068)/min. External cardiac work, total myocardial oxygen consumption (MVO&#8322;), and MEE were 4.24 (3.75&#8211;5.54) &#215; 10&#8309; mL&#183;mmHg/min, 16.5 (14.9&#8211;20.9) mL/min, and 17.7% (14.0&#8211;24.2%), respectively. Compared to males, females exhibited significantly higher corrected rest MBF (1.14 vs. 0.96 mL/min/g, <italic toggle="yes">p</italic>&#8201;=&#8201;0.032), stress kmono (0.078 vs. 0.070 /min, <italic toggle="yes">p</italic>&#8201;=&#8201;0.005), and total MVO&#8322; (17.6 vs. 15.5 mL/min, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003). Despite similar external cardiac work, myocardial external efficiency was significantly lower in females (15.5% vs. 20.3%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.009). MBF and oxidative metabolism were positively correlated in both sexes.</p></sec><sec><title>Conclusions</title><p id="Par3">This study assesses reference ranges and demonstrates significant sex-based differences in myocardial perfusion and oxidative metabolism using vasodilatory stress <sup>11</sup>C-acetate PET. These findings provide a valuable physiological framework for assessing perfusion-metabolism abnormalities in clinical practice.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13550-025-01311-w.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Myocardial perfusion</kwd><kwd>Oxidative metabolism</kwd><kwd>Sex-specific characteristics</kwd><kwd>Positron-Emission tomography (PET)</kwd><kwd>Vasodilator stress</kwd><kwd>Reference values</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">The pathophysiology of coronary artery disease (CAD) has shown substantial differences between the sexes. Characteristically, females tend to present more angina symptoms while are less likely to have obstructive CAD [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Clinical studies provide plausible explanations for such phenomena by showing the inherited differences in myocardial metabolism, indicating that oxidative metabolism (especially free fatty acid oxidation) is more pronounced in females [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], which contributes to increased oxygen demand.</p><p id="Par5">To noninvasively assess the sex-specific characteristics of myocardial metabolism, dynamic <sup>11</sup>C-acetate cardiac positron emission tomography (PET) has been utilized. It can quantify the mitochondrial oxidative metabolism by measuring the washout rate of <sup>11</sup>C-acetate from the myocardium. In addition, myocardial blood flow (MBF) can be quantified based on the compartment model specifically designed for <sup>11</sup>C-acetate PET [<xref ref-type="bibr" rid="CR5">5</xref>]. It provides quantitative metrics to establish the diagnosis and assess the severity coronary microvascular dysfunction, which is a particularly common pathophysiology in females [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. Thus, <sup>11</sup>C-acetate PET can be a powerful tool that can simultaneously evaluate the abnormalities in both myocardial perfusion and metabolism in patients with various cardiac disease entities [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] as well as CAD.</p><p id="Par6">However, existing data on the normal ranges of MBF and oxidative metabolism are limited to resting state or inotropic stress (e.g., exercise stress or dobutamine stress) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]; those required to set normal ranges under vasodilatory stress testing &#8212; which are frequently used for cardiac PET imaging in CAD [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>] &#8212; are lacking. Accordingly, we aim to evaluate reference ranges of MBF and myocardial oxidative metabolism under vasodilatory stress in healthy individuals and to explore sex-specific physiological differences with potential clinical relevance.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Study design and patients</title><p id="Par7">Healthy adults were prospectively recruited via poster advertisement. The inclusion criteria were age of 20&#8211;65 years old; no history of acute or chronic coronary syndrome; no known structural cardiac diseases; no underlying disease requiring medication. Exclusion criteria included abnormal echocardiography or poor echocardiographic window; contraindication to adenosine vasodilator stress testing; irregular heartbeat; other systemic conditions potentially affecting cardiac function. An experienced cardiologist of &gt;&#8201;10 year-experience (H.Y. K.) screened the participants regarding the health status and whether they fulfill the study criteria. Following the initial recruitment and echocardiographic screening, the final eighteen participants were screened through age-matching between females and males. All participants were asked to sign the consent upon a detailed study explanation. The health status of each participant was confirmed based on a standardized checklist, including: (1) no prior history of cardiovascular, metabolic, or systemic diseases; (2) normal findings on physical examination; (3) normal resting echocardiography with preserved LVEF and no structural abnormalities.</p></sec><sec id="Sec31"><title>2D Echocardiography and speckle tracking echocardiography</title><p id="Par8">Comprehensive transthoracic echocardiography (M-mode, 2-D, and Doppler) was performed using commercially available equipment (Vivid E95, GE Medical system, Milwaukee, WI). Left ventricular (LV) chamber size and wall thickness were measured by using 2016 American Society of Echocardiography (ASE)&#8217;s guideline and standards [<xref ref-type="bibr" rid="CR21">21</xref>]. LV mass was calculated using the conventional cube formula and LV hypertrophy (LVH) was determined according to the ASE&#8217;s chamber quantitation guideline (&gt;&#8201;95&#160;g/m<sup>2</sup> for women, &gt;115&#160;g/m<sup>2</sup> for men) [<xref ref-type="bibr" rid="CR21">21</xref>]. Analysis of the 2D STE images was performed with a software package (EchoPAC, GE Ultrasound, Haifa, Israel by an experienced investigator blinded to all clinical information of the enrolled subjects. Peak longitudinal strain was computed automatically for each LV segments and averaged value was reported as global strain.</p></sec><sec id="Sec4"><title>Cardiac <sup>11</sup>C-acetate PET</title><p id="Par9">For the stress testing for <sup>11</sup>C-acetate PET, the patients abstained of caffeine-containing foods or beverages at least 3 days from the PET study. Vasodilatory medication potentially affecting adenosine stress was also stopped for the corresponding period. Two intravenous lines, which were used for radiopharmaceutical injection and adenosine infusion, respectively, were inserted into the patient&#8217;s arms. After the patient lay down in a supine position, attenuation correction computed tomography (CT) was acquired. Resting PET images were obtained first, which simultaneously began with the intravenous <sup>11</sup>C-acetate injection by an autoinjector. Adenosine stress, which lasted for 6&#160;min, began immediately following the 20-minute dynamic resting PET acquisition. At 3&#160;min of adenosine infusion, which lasted for 6&#160;min, stress dose of <sup>11</sup>C-acetate was injected. The <sup>11</sup>C-acetate dosage and detailed dynamic image acquisition methodologies were as detailed previously [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec5"><title>Quantification of myocardial blood flow and oxidative metabolism</title><p id="Par10">From the rest and stress PET images, MBF was quantified based on the one-compartment model suggested by van den Hoff et al. [<xref ref-type="bibr" rid="CR5">5</xref>], which showed the best agreement with O-15 water PET [<xref ref-type="bibr" rid="CR17">17</xref>]. The ratio of stress MBF to rest MBF was defined as myocardial flow reserve (MFR). Using the downslope segment of the time-activity curve of <sup>11</sup>C-acetate PET (&#8805;&#8201;2&#160;min), the rate of washout was quantified (k<sub>mono</sub>) in the unit of /min. We also calculated k<sub>mono</sub> reserve, which was defined as the ratio of stress k<sub>mono</sub> to rest k<sub>mono</sub> [<xref ref-type="bibr" rid="CR22">22</xref>]. An analytic software package (Carimas&#8482;, Turku PET Centre, Finland) dedicated to quantifying dynamic PET parameters was utilized.</p><p id="Par11">Oxygen consumption (MVO<sub>2</sub>) was calculated by the formula suggested by previous reports [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. MVO<sub>2</sub> was multiplied by LV mass (measured by echocardiography) to obtain total MVO<sub>2</sub>.</p></sec><sec id="Sec6"><title>Calculation of myocardial work and efficiency</title><p id="Par12">External cardiac work was calculated by multiplying end-systolic pressure (ESP), stroke volume (SV), and heart rate (HR) (mmHg &#215; mL/min). To convert EW into Joules (J per minute), the result was multiplied by a factor of 1.33&#8201;&#215;&#8201;10<sup>&#8722;&#8201;4</sup>. Myocardial external efficiency (MEE) was calculated in percentage by dividing the externally measurable cardiac work with total MVO<sub>2</sub>, as previously described [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Resting LV myocardial mass and SV were derived from echocardiography, which was performed within 1 week of a specific <sup>11</sup>C-acetate PET.</p></sec><sec id="Sec7"><title>Statistical analyses</title><p id="Par13">Echocardiographic and PET parameters were compared between the groups along with demographic and clinical characteristics. Regarding continuous variables obtained from the imaging studies, mutual correlations were also analyzed. The comparisons of averages were performed based on either student&#8217;s t-test or Mann-Whitney U-test according to the data distribution assessed by Shapiro-Wilk normality test. Correlation analyses were performed either by Pearson&#8217;s correlation test or Spearman&#8217;s rank correlation test. Multiple linear regression was performed to assess the factor affecting imaging metrics. Statistical analyses were performed using R statistical package (version 4.4.2). A p-value&#8201;&lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Baseline characteristics</title><p id="Par14">The baseline characteristics of the study participants are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. The median age of the participants was 43 years (interquartile range [IQR] 40&#8211;51), with a total range of 34 to 66 years. No difference was found for age between sexes. Females had significantly smaller height and body weight, which resulted in smaller body surface area. On echocardiography, females showed significantly lower diastolic interventricular septal thickness (IVSd), posterior wall thickness (LVPWd), and relative well thickness (RWT). LV mass or LV mass index tended to be higher for males but were not significantly different. Among the diastolic parameters, E velocity was significantly higher in females (<italic toggle="yes">p</italic>&#8201;=&#8201;0.005). No significant difference was found for systolic function (e.g., LV ejection fraction, global longitudinal strain [GLS]). The comparisons regarding demographic and echocardiographic measurements between sexes are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par15">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Demographic and echocardiographic characteristics of study participants by sex</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Total (<italic toggle="yes">n</italic>&#8201;=&#8201;18)</th><th align="left" colspan="1" rowspan="1">Females (<italic toggle="yes">n</italic>&#8201;=&#8201;9)</th><th align="left" colspan="1" rowspan="1">Males (<italic toggle="yes">n</italic>&#8201;=&#8201;9)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Demographics</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">43 (IQR 40&#8211;51), range 34&#8211;66</td><td align="left" colspan="1" rowspan="1">43 (39&#8211;48), 34&#8211;66</td><td align="left" colspan="1" rowspan="1">43 (41&#8211;56), 35&#8211;64</td></tr><tr><td align="left" colspan="1" rowspan="1">Height (cm)</td><td align="left" colspan="1" rowspan="1">165 (161&#8211;170)</td><td align="left" colspan="1" rowspan="1">161 (159&#8211;164)*</td><td align="left" colspan="1" rowspan="1">170 (170&#8211;173)</td></tr><tr><td align="left" colspan="1" rowspan="1">Body weight (kg)</td><td align="left" colspan="1" rowspan="1">71 (59&#8211;78)</td><td align="left" colspan="1" rowspan="1">59 (53&#8211;72)*</td><td align="left" colspan="1" rowspan="1">74 (70&#8211;85)</td></tr><tr><td align="left" colspan="1" rowspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">24.0 (21.8&#8211;28.5)</td><td align="left" colspan="1" rowspan="1">22.1 (21.7&#8211;26.8)</td><td align="left" colspan="1" rowspan="1">25.3 (23.5&#8211;28.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Body surface area (m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">1.80 (1.64&#8211;1.92)</td><td align="left" colspan="1" rowspan="1">1.64 (1.52&#8211;1.78)*</td><td align="left" colspan="1" rowspan="1">1.89 (1.83&#8211;1.97)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Echocardiography</italic></bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">LVIDd (mm)</td><td align="left" colspan="1" rowspan="1">49 (44&#8211;52)</td><td align="left" colspan="1" rowspan="1">49 (46&#8211;52)</td><td align="left" colspan="1" rowspan="1">44 (42&#8211;52)</td></tr><tr><td align="left" colspan="1" rowspan="1">LVIDs (mm)</td><td align="left" colspan="1" rowspan="1">30 (25&#8211;33)</td><td align="left" colspan="1" rowspan="1">31 (29&#8211;33)</td><td align="left" colspan="1" rowspan="1">28 (25&#8211;31)</td></tr><tr><td align="left" colspan="1" rowspan="1">IVSd (mm)</td><td align="left" colspan="1" rowspan="1">8 (7&#8211;9)</td><td align="left" colspan="1" rowspan="1">6.9 (6.7&#8211;7.5)*</td><td align="left" colspan="1" rowspan="1">8.3 (7.9&#8211;8.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">LVPWd (mm)</td><td align="left" colspan="1" rowspan="1">7 (7&#8211;9)</td><td align="left" colspan="1" rowspan="1">6.5 (6.4&#8211;7.4)*</td><td align="left" colspan="1" rowspan="1">8.3 (7.7&#8211;8.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">TR Vmax (m/s)</td><td align="left" colspan="1" rowspan="1">2.11 (1.93&#8211;2.25)</td><td align="left" colspan="1" rowspan="1">2.04 (1.82&#8211;2.18)</td><td align="left" colspan="1" rowspan="1">2.14 (2.00&#8211;2.38)</td></tr><tr><td align="left" colspan="1" rowspan="1">E velocity (m/s)</td><td align="left" colspan="1" rowspan="1">0.67 (0.56&#8211;0.75)</td><td align="left" colspan="1" rowspan="1">0.75 (0.70&#8211;0.87)*</td><td align="left" colspan="1" rowspan="1">0.57 (0.55&#8211;0.65)</td></tr><tr><td align="left" colspan="1" rowspan="1">A velocity (m/s)</td><td align="left" colspan="1" rowspan="1">0.60 (0.52&#8211;0.77)</td><td align="left" colspan="1" rowspan="1">0.55 (0.39&#8211;0.80)</td><td align="left" colspan="1" rowspan="1">0.62 (0.57&#8211;0.69)</td></tr><tr><td align="left" colspan="1" rowspan="1">Septal E&#8217; (m/s)</td><td align="left" colspan="1" rowspan="1">0.11 (0.08&#8211;0.12)</td><td align="left" colspan="1" rowspan="1">0.12 (0.09&#8211;0.14)</td><td align="left" colspan="1" rowspan="1">0.10 (0.08&#8211;0.11)</td></tr><tr><td align="left" colspan="1" rowspan="1">E/septal E&#8217;</td><td align="left" colspan="1" rowspan="1">6.12 (5.45&#8211;7.01)</td><td align="left" colspan="1" rowspan="1">6.2 (5.5&#8211;9.3)</td><td align="left" colspan="1" rowspan="1">6.1 (5.8&#8211;6.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">DT (ms)</td><td align="left" colspan="1" rowspan="1">191 (170&#8211;222)</td><td align="left" colspan="1" rowspan="1">200.6 (173.2&#8211;223.2)</td><td align="left" colspan="1" rowspan="1">189.1 (163.7&#8211;196.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">LV mass (g)</td><td align="left" colspan="1" rowspan="1">114 (97&#8211;139)</td><td align="left" colspan="1" rowspan="1">109 (97&#8211;114)</td><td align="left" colspan="1" rowspan="1">117 (103&#8211;150)</td></tr><tr><td align="left" colspan="1" rowspan="1">LVMI (g/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">64 (55&#8211;72)</td><td align="left" colspan="1" rowspan="1">63.4 (58.1&#8211;68.3)</td><td align="left" colspan="1" rowspan="1">64.1 (54.9&#8211;75.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">RWT</td><td align="left" colspan="1" rowspan="1">0.31 (0.28&#8211;0.38)</td><td align="left" colspan="1" rowspan="1">0.28 (0.26&#8211;0.30)*</td><td align="left" colspan="1" rowspan="1">0.37 (0.32&#8211;0.40)</td></tr><tr><td align="left" colspan="1" rowspan="1">LVEF (%)</td><td align="left" colspan="1" rowspan="1">69 (62&#8211;73)</td><td align="left" colspan="1" rowspan="1">66 (62&#8211;73)</td><td align="left" colspan="1" rowspan="1">70 (63&#8211;73)</td></tr><tr><td align="left" colspan="1" rowspan="1">|GLS (%)|</td><td align="left" colspan="1" rowspan="1">-19.1 (-19.9&#8211;-17.9)</td><td align="left" colspan="1" rowspan="1">19.1 (18.8&#8211;20.3)</td><td align="left" colspan="1" rowspan="1">18.9 (17.1&#8211;19.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">Stroke volume (mL)</td><td align="left" colspan="1" rowspan="1">65 (57&#8211;82)</td><td align="left" colspan="1" rowspan="1">66.1 (57.4&#8211;80.0)</td><td align="left" colspan="1" rowspan="1">63.2 (60.6&#8211;82.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Hemodynamics at PET acquisition</italic></bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Stress</italic></bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Systolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">134 (120&#8211;144)</td><td align="left" colspan="1" rowspan="1">127 (121&#8211;138)</td><td align="left" colspan="1" rowspan="1">134 (122&#8211;137)</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">71 (62&#8211;81)</td><td align="left" colspan="1" rowspan="1">65 (60&#8211;73)</td><td align="left" colspan="1" rowspan="1">71 (64&#8211;81)</td></tr><tr><td align="left" colspan="1" rowspan="1">HR (/min)</td><td align="left" colspan="1" rowspan="1">88 (75&#8211;99)</td><td align="left" colspan="1" rowspan="1">92 (87&#8211;96)**</td><td align="left" colspan="1" rowspan="1">88 (80&#8211;97)**</td></tr><tr><td align="left" colspan="1" rowspan="1">RPP (mmHg/min)</td><td align="left" colspan="1" rowspan="1">11,834 (9424&#8211;13969)</td><td align="left" colspan="1" rowspan="1">12,192 (10080&#8211;13500)**</td><td align="left" colspan="1" rowspan="1">11,834 (10080&#8211;13600)**</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Rest</italic></bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Systolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">133 (128&#8211;153)</td><td align="left" colspan="1" rowspan="1">136 (130&#8211;141)</td><td align="left" colspan="1" rowspan="1">133 (131&#8211;148)</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">75 (70&#8211;83)</td><td align="left" colspan="1" rowspan="1">72 (66&#8211;74)</td><td align="left" colspan="1" rowspan="1">75 (71&#8211;81)</td></tr><tr><td align="left" colspan="1" rowspan="1">HR (/min)</td><td align="left" colspan="1" rowspan="1">63 (62&#8211;75)</td><td align="left" colspan="1" rowspan="1">66 (61&#8211;73)</td><td align="left" colspan="1" rowspan="1">63 (62&#8211;74)</td></tr><tr><td align="left" colspan="1" rowspan="1">RPP (mmHg/min)</td><td align="left" colspan="1" rowspan="1">9324 (8418&#8211;10232)</td><td align="left" colspan="1" rowspan="1">9384 (8712&#8211;10478)</td><td align="left" colspan="1" rowspan="1">9324 (8584&#8211;9956)</td></tr></tbody></table><table-wrap-foot><p>Values are given as mean&#8201;&#177;&#8201;standard deviation or median (interquartile range) according to the data distribution</p><p>BP, blood pressure; DT, deceleration time; GLS, global longitudinal strain; IVSd, end-diastolic interventricular septal thickness; LV, left ventricular; LVEF, left ventricular ejection fraction; LVIDd, end-diastolic left ventricular internal diameter; LVIDs, end-systolic left ventricular internal diameter; LVMI, left ventricular mass index; RWT, relative wall thickness; TR Vmax, tricuspid valve regurgitation peak velocity</p><p>RPP was calculated by multiplying SBP*HR; corrected rest MBF was calculated by dividing rest MBF with rest RPP; corrected MFR was calculated by dividing stress MBF with corrected rest MBF. Values are given as mean&#8201;&#177;&#8201;standard deviation or median (interquartile range) according to the data distribution. *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 vs. males, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 vs. rest</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Normal ranges of myocardial blood flow and oxidative metabolism and sex differences</title><p id="Par16">Table&#160;<xref rid="Tab2" ref-type="table">2</xref> presents the values of MBF and oxidative metabolism parameters measured by vasodilatory stress <sup>11</sup>C-acetate PET in eighteen healthy individuals. Females exhibited higher stress and rest MBF, with borderline statistical significance. After correction for rate-pressure product (RPP), rest MBF was significantly higher in females. MFR did not differ between sexes, regardless of RPP correction. Resting and stress hemodynamics (BP, heart rate, and RPP) were comparable between groups (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par17">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Myocardial perfusion and oxidative metabolism measured by <sup>11</sup>C-acetate PET in healthy subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Total (<italic toggle="yes">n</italic>&#8201;=&#8201;18)</th><th align="left" colspan="1" rowspan="1">Females (<italic toggle="yes">n</italic>&#8201;=&#8201;9)</th><th align="left" colspan="1" rowspan="1">Males (<italic toggle="yes">n</italic>&#8201;=&#8201;9)</th><th align="left" colspan="1" rowspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Stress MBF (mL/min/g)</td><td char="." align="char" colspan="1" rowspan="1">2.73 (2.24&#8211;3.11)</td><td char="." align="char" colspan="1" rowspan="1">3.11 (2.44&#8211;3.66)</td><td char="." align="char" colspan="1" rowspan="1">2.73 (2.24&#8211;3.11)</td><td char="." align="char" colspan="1" rowspan="1">0.093</td></tr><tr><td align="left" colspan="1" rowspan="1">Rest MBF (mL/min/g)</td><td char="." align="char" colspan="1" rowspan="1">0.99 (0.82&#8211;1.14)</td><td char="." align="char" colspan="1" rowspan="1">1.02 (0.96&#8211;1.14)</td><td char="." align="char" colspan="1" rowspan="1">0.82 (0.66&#8211;1.02)</td><td char="." align="char" colspan="1" rowspan="1">0.051</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Corrected rest MBF</p><p>(mL/min/g)</p></td><td char="." align="char" colspan="1" rowspan="1">1.07 (0.86&#8211;1.14)</td><td char="." align="char" colspan="1" rowspan="1">1.14 (1.07&#8211;1.21)*</td><td char="." align="char" colspan="1" rowspan="1">0.97 (0.78&#8211;1.02)</td><td char="." align="char" colspan="1" rowspan="1">0.013</td></tr><tr><td align="left" colspan="1" rowspan="1">MFR</td><td char="." align="char" colspan="1" rowspan="1">3.01 (2.36&#8211;3.46)</td><td char="." align="char" colspan="1" rowspan="1">2.98 (2.18&#8211;3.59)</td><td char="." align="char" colspan="1" rowspan="1">3.03 (2.62&#8211;3.28)</td><td char="." align="char" colspan="1" rowspan="1">0.605</td></tr><tr><td align="left" colspan="1" rowspan="1">Corrected MFR</td><td char="." align="char" colspan="1" rowspan="1">2.81 (2.35&#8211;3.20)</td><td char="." align="char" colspan="1" rowspan="1">2.80 (2.07&#8211;3.20)</td><td char="." align="char" colspan="1" rowspan="1">2.95 (2.51&#8211;3.23)</td><td char="." align="char" colspan="1" rowspan="1">0.480</td></tr><tr><td align="left" colspan="1" rowspan="1">Stress k<sub>mono</sub> (/min)</td><td char="." align="char" colspan="1" rowspan="1">0.074 (0.063&#8211;0.082)</td><td char="." align="char" colspan="1" rowspan="1">0.082 (0.081&#8211;0.093)*</td><td char="." align="char" colspan="1" rowspan="1">0.063 (0.051&#8211;0.067)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Rest k<sub>mono</sub> (/min)</td><td char="." align="char" colspan="1" rowspan="1">0.061 (0.050&#8211;0.068)</td><td char="." align="char" colspan="1" rowspan="1">0.068 (0.065&#8211;0.074)*</td><td char="." align="char" colspan="1" rowspan="1">0.050 (0.042&#8211;0.054)</td><td char="." align="char" colspan="1" rowspan="1">0.005</td></tr><tr><td align="left" colspan="1" rowspan="1">k<sub>mono</sub> reserve</td><td char="." align="char" colspan="1" rowspan="1">1.26 (1.12&#8211;1.29)</td><td char="." align="char" colspan="1" rowspan="1">1.21 (1.12&#8211;1.58)</td><td char="." align="char" colspan="1" rowspan="1">1.26 (1.20&#8211;1.29)</td><td char="." align="char" colspan="1" rowspan="1">0.930</td></tr><tr><td align="left" colspan="1" rowspan="1">Total MVO<sub>2</sub> (mL/min)</td><td char="." align="char" colspan="1" rowspan="1">16.5 (14.9&#8211;20.9)</td><td char="." align="char" colspan="1" rowspan="1">20.2 (16.4&#8211;21.2)*</td><td char="." align="char" colspan="1" rowspan="1">14.9 (12.6&#8211;16.1)</td><td char="." align="char" colspan="1" rowspan="1">0.014</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>External cardiac work</p><p>(*10<sup>5</sup> mL*mmHg/min)</p></td><td char="." align="char" colspan="1" rowspan="1">4.24 (3.75&#8211;5.54)</td><td char="." align="char" colspan="1" rowspan="1">4.20 (3.75&#8211;4.93)</td><td char="." align="char" colspan="1" rowspan="1">4.51 (3.86&#8211;5.54)</td><td char="." align="char" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">MEE (%)</td><td char="." align="char" colspan="1" rowspan="1">17.7 (14.0&#8211;24.2)</td><td char="." align="char" colspan="1" rowspan="1">14.7 (12.8&#8211;16.3)*</td><td char="." align="char" colspan="1" rowspan="1">20.2 (19.4&#8211;29.5)</td><td char="." align="char" colspan="1" rowspan="1">0.022</td></tr></tbody></table><table-wrap-foot><p>*<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 vs. males</p><p>Values are given as mean&#8201;&#177;&#8201;standard deviation or median (interquartile range) according to the data distribution</p><p>kmono, mono-exponentially fitted myocardial <sup>11</sup>C-acetate clearance rate (oxidative metabolism); MBF, myocardial blood flow; MEE, myocardial external efficiency; MFR, myocardial flow reserve; MVO2, myocardial oxygen consumption rate; PET, positron emission tomography</p></table-wrap-foot></table-wrap>
</p><p id="Par18">Regarding oxidative metabolism, k<sub>mono</sub> increased by a median of 0.013 (25%) during adenosine stress, with no significant difference in the degree of increase between females (0.012, 21%) and males (0.014, 26%). Notably, females demonstrated consistently higher k<sub>mono</sub> values at both rest and stress, with non-overlapping interquartile ranges. This resulted in significantly higher total MVO<sub>2</sub> in females, despite having a lower median LV mass (109&#160;g vs. 117&#160;g; <italic toggle="yes">p</italic>&#8201;=&#8201;0.112). Notably, myocardial external efficiency (MEE) was significantly lower in females, despite similar external cardiac work (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec11"><title>Correlations of MBF and oxidative metabolism with demographics and echocardiographic indices</title><p id="Par19">There was a modest negative linear correlation between age and MEE (&#961;&#8201;=&#8201;0.477, <italic toggle="yes">p</italic>&#8201;=&#8201;0.045) (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A). In contrast, age showed no significant correlations with MBF, MFR, k<sub>mono</sub>, k<sub>mono</sub> reserve, or hemodynamics during PET acquisition.</p><p id="Par20">Among echocardiographic LV function indices, the absolute value of GLS (|GLS|) demonstrated significant positive correlations with rest MBF and rest k<sub>mono</sub> (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B-C). These correlations remained significant even after correction of rest MBF by RPP (&#961;&#8201;=&#8201;0.513, <italic toggle="yes">p</italic>&#8201;=&#8201;0.035).</p><p id="Par21">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Correlation of <sup>11</sup>C-acetate PET parameters with age and LV strain. Age and MEE showed a negative linear correlation (<bold>A</bold>). Rest MBF (<bold>B</bold>) and k<sub>mono</sub> (C) positively correlated with the absolute value of GLS (|GLS|). GLS, global longitudinal strain; k<sub>mono</sub>, mono-exponentially fitted myocardial <sup>11</sup>C-acetate clearance rate (oxidative metabolism); LV, left ventricular; MBF, myocardial blood flow; MEE, myocardial external efficiency; PET, positron emission tomography</p></caption><graphic id="d33e1087" position="float" orientation="portrait" xlink:href="13550_2025_1311_Fig1_HTML.jpg"/></fig>
</p><p id="Par22">Interestingly, |GLS| did not correlate with stress MBF or stress k<sub>mono</sub>. Instead, inverse relationship were observed between |GLS| vs. MFR (&#961; = -0.578, <italic toggle="yes">p</italic>&#8201;=&#8201;0.015), as well as between k<sub>mono</sub> reserve (&#961; = -0.625, <italic toggle="yes">p</italic>&#8201;=&#8201;0.007).</p></sec><sec id="Sec12"><title>Correlations among MBF, oxidative metabolism, and hemodynamics</title><p id="Par23">Among PET parameters, MBF and k<sub>mono</sub> showed significant positive correlations at both rest and stress conditions. Additionally, MFR and k<sub>mono</sub> reserve were also positively correlated (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). Importantly, these relationships remained significant after the correction of rest MBF by RPP: corrected rest MBF vs. rest k<sub>mono</sub> (&#961;&#8201;=&#8201;0.550, <italic toggle="yes">p</italic>&#8201;=&#8201;0.018); corrected MFR vs. k<sub>mono</sub> reserve (&#961;&#8201;=&#8201;0. 731, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><p id="Par24">Hemodynamic parameters during PET acquisition also influenced these findings. RPP during stress and at rest significantly correlated with stress MBF (&#961;&#8201;=&#8201;0.618, <italic toggle="yes">p</italic>&#8201;=&#8201;0.006) and rest k<sub>mono</sub> (&#961;&#8201;=&#8201;0.473, <italic toggle="yes">p</italic>&#8201;=&#8201;0.047), respectively. This correlation appeared to be primarily driven by HR, as no significant association was found with systolic or diastolic BP. Furthermore, the stress-to-rest ratio of RPP significantly correlated with both MFR (&#961;&#8201;=&#8201;0.620, <italic toggle="yes">p</italic>&#8201;=&#8201;0.007) and k<sub>mono</sub> reserve (&#961;&#8201;=&#8201;0.596, <italic toggle="yes">p</italic>&#8201;=&#8201;0.009). Interestingly, unlike the MBF and k<sub>mono</sub> correlations, reserve parameters demonstrated significant associations with BP rather than HR (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec13"><title>Factors affecting LV function and oxidative metabolism</title><p id="Par25">Multiple linear regression analyses were performed to assess factors associated with LV function (|GLS|), myocardial oxidative metabolism (rest k<sub>mono</sub>), and its efficiency (MEE). The analysis revealed that rest MBF was more closely associated (&#946;&#8201;=&#8201;0.657, <italic toggle="yes">p</italic>&#8201;=&#8201;0.079) with |GLS| than rest k<sub>mono</sub> (&#946;&#8201;=&#8201;0.097, <italic toggle="yes">p</italic>&#8201;=&#8201;0.783). Both sex (&#946; = -0.551, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003 for males) and rest RPP (&#946;&#8201;=&#8201;0.536, <italic toggle="yes">p</italic>&#8201;=&#8201;0.003) were significant independent predictors of rest k<sub>mono</sub> in the multivariate analysis. Notably, sex (&#946;&#8201;=&#8201;0.483, <italic toggle="yes">p</italic>&#8201;=&#8201;0.036 for males) demonstrated a stronger association with MEE compared to age (&#946; = -0.413, <italic toggle="yes">p</italic>&#8201;=&#8201;0.068).</p><p id="Par26">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Correlations among myocardial perfusion and oxidative metabolism. MBF and k<sub>mono</sub> showed significant positive linear correlations both during stress and at rest (<bold>A-B</bold>). Stress-to-rest ratios of these metrics (MFR vs. k<sub>mono</sub> reserve) also showed a significant positive linear correlation (<bold>C</bold>). MFR, myocardial flow reserve</p></caption><graphic id="d33e1195" position="float" orientation="portrait" xlink:href="13550_2025_1311_Fig2_HTML.jpg"/></fig>
</p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par27">This study evaluated sex-specific reference ranges for MBF and myocardial oxidative metabolism in healthy individuals using vasodilatory stress <sup>11</sup>C-acetate PET. Adenosine stress induced&#8201;&gt;&#8201;20% increase of oxidative metabolism, which correlated with that in myocardial perfusion. Females demonstrated higher oxidative metabolism and lower metabolic efficiency (approximately 73% of that of males). MBF and oxidative metabolism significantly correlated with each other.</p><p id="Par28">In comparison with previously published data on normal ranges of <sup>11</sup>C-acetate PET parameters, our findings demonstrate comparable values for resting MBF and k<sub>mono</sub> (Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>). However, significant discrepancies are observed in stress-induced responses. As shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, when the data from the present (closed blue dot) and previous studies with available stress MBF and k<sub>mono</sub> values [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>], dobutamine and exercise stress testing seems to induce a similar or lesser extent of increase in MBF but a much more remarkable increase in oxidative metabolism. This suggests that dobutamine and exercise stress drastically increase myocardial oxygen demand but may not provide sufficient blood supply to match the demand, that can be critically risky to some conditions [<xref ref-type="bibr" rid="CR23">23</xref>]. Also, this probably contributes to the superior efficacy of dobutamine stress testing in the evaluation of stress-induced wall motion abnormality [<xref ref-type="bibr" rid="CR24">24</xref>], but relatively inferior efficacy to induce flow heterogeneity in myocardial perfusion imaging [<xref ref-type="bibr" rid="CR25">25</xref>]. These observations underscore the distinct hemodynamic responses between stress modalities, highlighting the need for modality-specific reference ranges. Our study provides a unique normal dataset of vasodilator stress <sup>11</sup>C-acetate PET to simultaneously assess vasodilatory capacity relative to oxygen demand in patients with various cardiac diseases. Interestingly, the increase in k<sub>mono</sub> by adenosine stress was only 25% of the resting state, similar to patients with recent acute ST-segment elevation myocardial infarction (<italic toggle="yes">n</italic>&#8201;=&#8201;30, 77% males, median 3 days post-infarction) [<xref ref-type="bibr" rid="CR22">22</xref>]. In that study, the median value of k<sub>mono</sub> reserve (referred to as oxidative metabolism reserve [OMR]) was almost identical to the present study, but with a wider distribution (1.25 [0.87&#8211;1.74]). It did not differ between infarct-related artery territory (IRAs) vs. non-IRA territory or non-IRA territories with vs. without significant stenosis.</p><p id="Par29">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Comparison of myocardial perfusion and oxidative metabolism among studies with available stress measurements. The mark and error bars represent median with interquartile range or mean&#8201;&#177;&#8201;standard deviation. The MBF values of AbouEzzedine et al. [<xref ref-type="bibr" rid="CR10">10</xref>] were derived using the median LV mass from the study data; the k<sub>mono</sub> values of Porenta et al. [<xref ref-type="bibr" rid="CR12">12</xref>] were derived from the equation for calculating MVO<sub>2</sub>. MFR values from the previous studies were calculated by dividing the representative stress MBF with rest MBF values (median or mean); the error bars of MFR could not be expressed due to lack of data. Error bars indicate standard deviation or (interquartile) ranges according to study statistics</p></caption><graphic id="d33e1265" position="float" orientation="portrait" xlink:href="13550_2025_1311_Fig3_HTML.jpg"/></fig>
</p><p id="Par30">The sex differences in oxidative metabolism were clearly recognized in the present study, consistent with the previous reports [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Female hearts are considered to consume more oxygen, reportedly due to different substrate preference in energy production during the resting state [<xref ref-type="bibr" rid="CR3">3</xref>]. Such differences also exist in the non-cardiac skeletal muscles; the enzymatic and genetic studies in the limb muscles revealed greater capacity of beta-oxidation and lower glycolytic potential [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Oxidative metabolism has been shown to tightly correlate with MBF [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. It was reproduced in our data and further extrapolated to vasodilatory stress as well. The increase in blood flow is essential for the myocardium to match the oxygen demand (e.g., tachycardia). Adenosine stress caused increase in HR and RPP, which paralleled with increased k<sub>mono</sub> by 25% and about 3-fold increase in MBF. Rest MBF was higher in females and even statistically more significant after RPP correction. Similar results were observed by Duvernoy et al. [<xref ref-type="bibr" rid="CR4">4</xref>], which was especially remarkable among diabetic subjects. Even with similar amount of external cardiac workload, females may have much higher oxidative metabolism demanding incremental amount of oxygen (&#8776;&#8201;blood flow) relative to males, as reflected in a markedly lower MEE of females relative to males. It provides plausible explanations regarding the vulnerability of females to anginal symptoms and adverse cardiac events despite milder degrees of CAD as compared to males.</p><p id="Par31">These physiological differences in myocardial perfusion and metabolism between sexes offer critical insight into observed disparities in invasive physiological indices and clinical outcomes. For example, women with deferred revascularization based on an fractional flow reserve (FFR)&#8201;&gt;&#8201;0.80 have shown higher rates of adverse events compared to men [<xref ref-type="bibr" rid="CR30">30</xref>], underscoring that epicardial-focused assessment may overlook microvascular and metabolic factors. The higher resting MBF and oxidative metabolism observed in our study provide a pathophysiological rationale for this discrepancy, suggesting that female myocardium&#8217;s elevated baseline demand may reduce the reliability of FFR-based decision-making. Likewise, lower CFR values in women, often attributed to higher resting coronary flow rather than true impairment [<xref ref-type="bibr" rid="CR31">31</xref>], are consistent with our findings. This supports interpreting reduced CFR in women as a physiologic adaptation rather than pathology. The role of index of microcirculatory resistance (IMR) in sex differences remains debated [<xref ref-type="bibr" rid="CR32">32</xref>]. Our demonstration of higher resting myocardial demand and lower efficiency in females offers compelling mechanistic support for the variability observed in IMR studies, indicating that sex-specific metabolic profiles may predispose women to microvascular resistance elevations. Together, these findings highlight the essential role of sex-specific physiology in interpreting invasive indices and underscore the unique contribution of our study in providing the metabolic background for these observed clinical discrepancies.</p><sec id="Sec15"><title>Study limitations</title><p id="Par32">The current study analyzed only adenosine vasodilatory stress testing, which is most commonly used for cardiac PET. However, the vasodilatory agents (e.g., regadenoson, dipyridamole) for cardiac PET varies by countries, which may limit the generalizability of the data. There were elderly participants with age&#8201;&gt;&#8201;60 years old in our study, who could have high likelihood of subclinical CAD. However, all their stress MBF were above 2.17 mL/min/g (all MFR&#8201;&gt;&#8201;2.0), corresponding to &#8216;excellent coronary flow capacity&#8217; suggested by Gould et al. [<xref ref-type="bibr" rid="CR33">33</xref>]. The information on menstrual phase was not available for the in premenopausal women among the participants of the present study. However, it was not found significantly affect oxygen consumption in a previous study by Peterson et al. [<xref ref-type="bibr" rid="CR3">3</xref>]. Additionally, although this study focused on healthy individuals, extrapolation to patient populations requires caution. Finally, the relatively small sample size of eighteen participants may limit the statistical power and generalizability of our findings. Nevertheless, this sample size is comparable to that of prior studies utilizing dynamic <sup>11</sup>C-acetate PET in healthy individuals, and our study provides important exploratory data for establishing sex-specific reference values and physiological insights that can guide future larger-scale investigations.</p></sec></sec><sec id="Sec16"><title>Conclusion</title><p id="Par33">In conclusion, this study provides preliminary normal reference ranges of MBF and oxidative metabolism under vasodilatory stress <sup>11</sup>C-acetate PET in healthy individuals. Importantly, it suggests potential sex-specific differences, with females exhibiting higher baseline myocardial oxygen demand and lower metabolic efficiency. These physiological disparities provide critical insight into observed sex-based variations in invasive and non-invasive coronary physiological indices and support the importance of sex-tailored interpretation in clinical decision-making. Further large-scale studies are warranted to validate the clinical impact of integrating sex-specific metabolic profiles into patient evaluation and risk stratification strategies.</p></sec><sec id="Sec17" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="13550_2025_1311_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The study was conducted with the support of the 2021 Health Fellowship Foundation (Recipient: HYK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S-GC and HYK contributed to the study conception and design. S-GC and HYK performed the material preparation, data collection, and analysis. The first draft of the manuscript was written by S-GC. All authors (S-GC, HYK, KSP, JK, JBM, NL, HP, JYC, HJY, YKA, J-HD, E-SS, KHK, and H-CS) commented on previous versions of the manuscript and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar5"><title>Ethics approval and consent to participate</title><p id="Par34">The study was approved by the Institutional Review Board of Chonnam National University Hospital (IRB No. CNUH-2019-173), and written informed consent was obtained from all participants.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par35">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing Interests</title><p id="Par36">The authors have declared that no competing interests exist.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milcent</surname><given-names>C</given-names></name><name name-style="western"><surname>Dormont</surname><given-names>B</given-names></name><name name-style="western"><surname>Durand-Zaleski</surname><given-names>I</given-names></name><name name-style="western"><surname>Steg</surname><given-names>PG</given-names></name></person-group><article-title>Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>833</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.664979</pub-id><pub-id pub-id-type="pmid">17309933</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation. 2007;115:833&#8211;9. 10.1161/CIRCULATIONAHA.106.664979.<pub-id pub-id-type="pmid">17309933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.106.664979</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maas</surname><given-names>AH</given-names></name><name name-style="western"><surname>Appelman</surname><given-names>YE</given-names></name></person-group><article-title>Gender differences in coronary heart disease</article-title><source>Neth Heart J</source><year>2010</year><volume>18</volume><fpage>598</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1007/s12471-010-0841-y</pub-id><pub-id pub-id-type="pmid">21301622</pub-id><pub-id pub-id-type="pmcid">PMC3018605</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18:598&#8211;602. 10.1007/s12471-010-0841-y.<pub-id pub-id-type="pmid">21301622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12471-010-0841-y</pub-id><pub-id pub-id-type="pmcid">PMC3018605</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>LR</given-names></name><name name-style="western"><surname>Soto</surname><given-names>PF</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>P</given-names></name><name name-style="western"><surname>Schechtman</surname><given-names>KB</given-names></name><name name-style="western"><surname>Dence</surname><given-names>C</given-names></name><name name-style="western"><surname>Gropler</surname><given-names>RJ</given-names></name></person-group><article-title>Sex differences in myocardial oxygen and glucose metabolism</article-title><source>J Nucl Cardiol</source><year>2007</year><volume>14</volume><fpage>573</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.nuclcard.2007.03.001</pub-id><pub-id pub-id-type="pmid">17679067</pub-id><pub-id pub-id-type="pmcid">PMC2034520</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol. 2007;14:573&#8211;81. 10.1016/j.nuclcard.2007.03.001.<pub-id pub-id-type="pmid">17679067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nuclcard.2007.03.001</pub-id><pub-id pub-id-type="pmcid">PMC2034520</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duvernoy</surname><given-names>CS</given-names></name><name name-style="western"><surname>Raffel</surname><given-names>DM</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>SD</given-names></name><name name-style="western"><surname>Jaiswal</surname><given-names>M</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>G</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes</article-title><source>J Nucl Cardiol</source><year>2016</year><volume>23</volume><fpage>960</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s12350-016-0434-2</pub-id><pub-id pub-id-type="pmid">27146882</pub-id><pub-id pub-id-type="pmcid">PMC5103640</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Duvernoy CS, Raffel DM, Swanson SD, Jaiswal M, Mueller G, Ibrahim ES, et al. Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes. J Nucl Cardiol. 2016;23:960&#8211;9. 10.1007/s12350-016-0434-2.<pub-id pub-id-type="pmid">27146882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-016-0434-2</pub-id><pub-id pub-id-type="pmcid">PMC5103640</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Hoff</surname><given-names>J</given-names></name><name name-style="western"><surname>Burchert</surname><given-names>W</given-names></name><name name-style="western"><surname>Borner</surname><given-names>AR</given-names></name><name name-style="western"><surname>Fricke</surname><given-names>H</given-names></name><name name-style="western"><surname>Kuhnel</surname><given-names>G</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET</article-title><source>J Nucl Med</source><year>2001</year><volume>42</volume><fpage>1174</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">11483676</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">van den Hoff J, Burchert W, Borner AR, Fricke H, Kuhnel G, Meyer GJ, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med. 2001;42:1174&#8211;82.<pub-id pub-id-type="pmid">11483676</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, AHA/ACC/ASE/CHEST, /SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368-e454. 10.1161/CIR.0000000000001030<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000001030</pub-id><pub-id pub-id-type="pmid">34709928</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>HR</given-names></name><name name-style="western"><surname>Bairey Merz</surname><given-names>CN</given-names></name><name name-style="western"><surname>Berry</surname><given-names>C</given-names></name><name name-style="western"><surname>Samuel</surname><given-names>R</given-names></name><name name-style="western"><surname>Saw</surname><given-names>J</given-names></name><name name-style="western"><surname>Smilowitz</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Coronary arterial function and disease in women with no obstructive coronary arteries</article-title><source>Circ Res</source><year>2022</year><volume>130</volume><fpage>529</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.319892</pub-id><pub-id pub-id-type="pmid">35175840</pub-id><pub-id pub-id-type="pmcid">PMC8911308</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Reynolds HR, Bairey Merz CN, Berry C, Samuel R, Saw J, Smilowitz NR, et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circ Res. 2022;130:529&#8211;51. 10.1161/CIRCRESAHA.121.319892.<pub-id pub-id-type="pmid">35175840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.121.319892</pub-id><pub-id pub-id-type="pmcid">PMC8911308</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taqueti</surname><given-names>VR</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Cook</surname><given-names>NR</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>VL</given-names></name><name name-style="western"><surname>Shah</surname><given-names>NR</given-names></name><name name-style="western"><surname>Foster</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease</article-title><source>Circulation</source><year>2017</year><volume>135</volume><fpage>566</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.023266</pub-id><pub-id pub-id-type="pmid">27881570</pub-id><pub-id pub-id-type="pmcid">PMC5459611</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Taqueti VR, Shaw LJ, Cook NR, Murthy VL, Shah NR, Foster CR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135:566&#8211;77. 10.1161/CIRCULATIONAHA.116.023266.<pub-id pub-id-type="pmid">27881570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.116.023266</pub-id><pub-id pub-id-type="pmcid">PMC5459611</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Fang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic (11)C-Acetate positron emission tomography</article-title><source>J Nucl Cardiol</source><year>2022</year><volume>29</volume><fpage>278</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/s12350-020-02214-0</pub-id><pub-id pub-id-type="pmid">32557237</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Shi X, Liu S, Lin X, Zhao X, Fang L, Ding J, et al. Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic (11)C-Acetate positron emission tomography. J Nucl Cardiol. 2022;29:278&#8211;88. 10.1007/s12350-020-02214-0.<pub-id pub-id-type="pmid">32557237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-020-02214-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>AbouEzzeddine</surname><given-names>OF</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Borlaug</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mullan</surname><given-names>BP</given-names></name><name name-style="western"><surname>Behfar</surname><given-names>A</given-names></name><name name-style="western"><surname>Pislaru</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Myocardial energetics in heart failure with preserved ejection fraction</article-title><source>Circ Heart Fail</source><year>2019</year><volume>12</volume><fpage>e006240</fpage><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.119.006240</pub-id><pub-id pub-id-type="pmid">31610726</pub-id><pub-id pub-id-type="pmcid">PMC6863599</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">AbouEzzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, et al. Myocardial energetics in heart failure with preserved ejection fraction. Circ Heart Fail. 2019;12:e006240. 10.1161/CIRCHEARTFAILURE.119.006240.<pub-id pub-id-type="pmid">31610726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCHEARTFAILURE.119.006240</pub-id><pub-id pub-id-type="pmcid">PMC6863599</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorensen</surname><given-names>J</given-names></name><name name-style="western"><surname>Valind</surname><given-names>S</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>LG</given-names></name></person-group><article-title>Simultaneous quantification of myocardial perfusion, oxidative metabolism, cardiac efficiency and pump function at rest and during supine bicycle exercise using 1-11&#160;C-acetate PET&#8211;a pilot study</article-title><source>Clin Physiol Funct Imaging</source><year>2010</year><volume>30</volume><fpage>279</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1111/j.1475-097X.2010.00938.x</pub-id><pub-id pub-id-type="pmid">20662878</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Sorensen J, Valind S, Andersson LG. Simultaneous quantification of myocardial perfusion, oxidative metabolism, cardiac efficiency and pump function at rest and during supine bicycle exercise using 1-11&#160;C-acetate PET&#8211;a pilot study. Clin Physiol Funct Imaging. 2010;30:279&#8211;84. 10.1111/j.1475-097X.2010.00938.x.<pub-id pub-id-type="pmid">20662878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1475-097X.2010.00938.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porenta</surname><given-names>G</given-names></name><name name-style="western"><surname>Cherry</surname><given-names>S</given-names></name><name name-style="western"><surname>Czernin</surname><given-names>J</given-names></name><name name-style="western"><surname>Brunken</surname><given-names>R</given-names></name><name name-style="western"><surname>Kuhle</surname><given-names>W</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging</article-title><source>Eur J Nucl Med</source><year>1999</year><volume>26</volume><fpage>1465</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s002590050480</pub-id><pub-id pub-id-type="pmid">10552089</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Porenta G, Cherry S, Czernin J, Brunken R, Kuhle W, Hashimoto T, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med. 1999;26:1465&#8211;74. 10.1007/s002590050480.<pub-id pub-id-type="pmid">10552089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002590050480</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Guclu A, Knaapen P, Harms HJ, Parbhudayal RY, Michels M, Lammertsma AA, et al. Disease Stage-Dependent changes in cardiac contractile performance and oxygen utilization underlie reduced myocardial efficiency in human inherited hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2017;10. 10.1161/CIRCIMAGING.116.005604.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCIMAGING.116.005604</pub-id><pub-id pub-id-type="pmid">28476777</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansson</surname><given-names>NH</given-names></name><name name-style="western"><surname>Harms</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WY</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name><name name-style="western"><surname>Tolbod</surname><given-names>LP</given-names></name><name name-style="western"><surname>Frokiaer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Test-retest repeatability of myocardial oxidative metabolism and efficiency using standalone dynamic (11)C-acetate PET and multimodality approaches in healthy controls</article-title><source>J Nucl Cardiol</source><year>2018</year><volume>25</volume><fpage>1929</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s12350-018-1302-z</pub-id><pub-id pub-id-type="pmid">29855984</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Hansson NH, Harms HJ, Kim WY, Nielsen R, Tolbod LP, Frokiaer J, et al. Test-retest repeatability of myocardial oxidative metabolism and efficiency using standalone dynamic (11)C-acetate PET and multimodality approaches in healthy controls. J Nucl Cardiol. 2018;25:1929&#8211;36. 10.1007/s12350-018-1302-z.<pub-id pub-id-type="pmid">29855984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-018-1302-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sciacca</surname><given-names>RR</given-names></name><name name-style="western"><surname>Akinboboye</surname><given-names>O</given-names></name><name name-style="western"><surname>Chou</surname><given-names>RL</given-names></name><name name-style="western"><surname>Epstein</surname><given-names>S</given-names></name><name name-style="western"><surname>Bergmann</surname><given-names>SR</given-names></name></person-group><article-title>Measurement of myocardial blood flow with PET using 1-11&#160;C-acetate</article-title><source>J Nucl Med</source><year>2001</year><volume>42</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11197982</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Sciacca RR, Akinboboye O, Chou RL, Epstein S, Bergmann SR. Measurement of myocardial blood flow with PET using 1-11&#160;C-acetate. J Nucl Med. 2001;42:63&#8211;70.<pub-id pub-id-type="pmid">11197982</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>KT</given-names></name><name name-style="western"><surname>Yeatman</surname><given-names>LA</given-names></name><name name-style="western"><surname>Buxton</surname><given-names>DB</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate</article-title><source>J Nucl Med</source><year>1998</year><volume>39</volume><fpage>272</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9476935</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Sun KT, Yeatman LA, Buxton DB, Chen K, Johnson JA, Huang SC, et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med. 1998;39:272&#8211;80.<pub-id pub-id-type="pmid">9476935</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timmer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Lubberink</surname><given-names>M</given-names></name><name name-style="western"><surname>Germans</surname><given-names>T</given-names></name><name name-style="western"><surname>Gotte</surname><given-names>MJ</given-names></name><name name-style="western"><surname>ten Berg</surname><given-names>JM</given-names></name><name name-style="western"><surname>ten Cate</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Potential of [11&#160;C]acetate for measuring myocardial blood flow: studies in normal subjects and patients with hypertrophic cardiomyopathy</article-title><source>J Nucl Cardiol</source><year>2010</year><volume>17</volume><fpage>264</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s12350-009-9181-y</pub-id><pub-id pub-id-type="pmid">20039151</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Timmer SA, Lubberink M, Germans T, Gotte MJ, ten Berg JM, ten Cate FJ, et al. Potential of [11&#160;C]acetate for measuring myocardial blood flow: studies in normal subjects and patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2010;17:264&#8211;75. 10.1007/s12350-009-9181-y.<pub-id pub-id-type="pmid">20039151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-009-9181-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gould</surname><given-names>KL</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>NP</given-names></name><name name-style="western"><surname>Roby</surname><given-names>AE</given-names></name><name name-style="western"><surname>Bui</surname><given-names>L</given-names></name><name name-style="western"><surname>Kitkungvan</surname><given-names>D</given-names></name><name name-style="western"><surname>Patel</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications</article-title><source>Eur Heart J</source><year>2024</year><volume>45</volume><fpage>181</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehad579</pub-id><pub-id pub-id-type="pmid">37634192</pub-id><pub-id pub-id-type="pmcid">PMC10787661</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Gould KL, Johnson NP, Roby AE, Bui L, Kitkungvan D, Patel MB, et al. Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications. Eur Heart J. 2024;45:181&#8211;94. 10.1093/eurheartj/ehad579.<pub-id pub-id-type="pmid">37634192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehad579</pub-id><pub-id pub-id-type="pmcid">PMC10787661</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>KK</given-names></name><name name-style="western"><surname>Spertus</surname><given-names>JA</given-names></name><name name-style="western"><surname>Chan</surname><given-names>PS</given-names></name><name name-style="western"><surname>Sperry</surname><given-names>BW</given-names></name><name name-style="western"><surname>Al Badarin</surname><given-names>F</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>KF</given-names></name><etal/></person-group><article-title>Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization</article-title><source>Eur Heart J</source><year>2020</year><volume>41</volume><fpage>759</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz389</pub-id><pub-id pub-id-type="pmid">31228200</pub-id><pub-id pub-id-type="pmcid">PMC7828468</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Patel KK, Spertus JA, Chan PS, Sperry BW, Al Badarin F, Kennedy KF, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization. Eur Heart J. 2020;41:759&#8211;68. 10.1093/eurheartj/ehz389.<pub-id pub-id-type="pmid">31228200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehz389</pub-id><pub-id pub-id-type="pmcid">PMC7828468</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taqueti</surname><given-names>VR</given-names></name><name name-style="western"><surname>Hachamovitch</surname><given-names>R</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>VL</given-names></name><name name-style="western"><surname>Naya</surname><given-names>M</given-names></name><name name-style="western"><surname>Foster</surname><given-names>CR</given-names></name><name name-style="western"><surname>Hainer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization</article-title><source>Circulation</source><year>2015</year><volume>131</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.1161/Circulationaha.114.011939</pub-id><pub-id pub-id-type="pmid">25400060</pub-id><pub-id pub-id-type="pmcid">PMC4286486</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19&#8211;. 10.1161/Circulationaha.114.011939.<pub-id pub-id-type="pmid">25400060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.114.011939</pub-id><pub-id pub-id-type="pmcid">PMC4286486</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>RM</given-names></name><name name-style="western"><surname>Badano</surname><given-names>LP</given-names></name><name name-style="western"><surname>Mor-Avi</surname><given-names>V</given-names></name><name name-style="western"><surname>Afilalo</surname><given-names>J</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>A</given-names></name><name name-style="western"><surname>Ernande</surname><given-names>L</given-names></name><etal/></person-group><article-title>Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging</article-title><source>J Am Soc Echocardiography: Official Publication Am Soc Echocardiography</source><year>2015</year><volume>28</volume><fpage>1</fpage><lpage>e3914</lpage><pub-id pub-id-type="doi">10.1016/j.echo.2014.10.003</pub-id><pub-id pub-id-type="pmid">25559473</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiography: Official Publication Am Soc Echocardiography. 2015;28:1&#8211;e3914. 10.1016/j.echo.2014.10.003.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.echo.2014.10.003</pub-id><pub-id pub-id-type="pmid">25559473</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>SG</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Park</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Moon</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Evaluation of Non-infarct-Related arteries using 11&#160;C-acetate PET in STEMI with multivessel disease</article-title><source>J Cardiovasc Imaging</source><year>2022</year><volume>30</volume><fpage>169</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.4250/jcvi.2021.0189</pub-id><pub-id pub-id-type="pmid">35879252</pub-id><pub-id pub-id-type="pmcid">PMC9314231</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Cho SG, Kim M, Lee SH, Park KS, Kim J, Moon JB, et al. Evaluation of Non-infarct-Related arteries using 11&#160;C-acetate PET in STEMI with multivessel disease. J Cardiovasc Imaging. 2022;30:169&#8211;80. 10.4250/jcvi.2021.0189.<pub-id pub-id-type="pmid">35879252</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4250/jcvi.2021.0189</pub-id><pub-id pub-id-type="pmcid">PMC9314231</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henzlova</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Duvall</surname><given-names>WL</given-names></name><name name-style="western"><surname>Einstein</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Travin</surname><given-names>MI</given-names></name><name name-style="western"><surname>Verberne</surname><given-names>HJ</given-names></name></person-group><article-title>ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers</article-title><source>J Nucl Cardiol</source><year>2016</year><volume>23</volume><fpage>606</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1007/s12350-015-0387-x</pub-id><pub-id pub-id-type="pmid">26914678</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606&#8211;39. 10.1007/s12350-015-0387-x.<pub-id pub-id-type="pmid">26914678</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12350-015-0387-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paetsch</surname><given-names>I</given-names></name><name name-style="western"><surname>Jahnke</surname><given-names>C</given-names></name><name name-style="western"><surname>Wahl</surname><given-names>A</given-names></name><name name-style="western"><surname>Gebker</surname><given-names>R</given-names></name><name name-style="western"><surname>Neuss</surname><given-names>M</given-names></name><name name-style="western"><surname>Fleck</surname><given-names>E</given-names></name><etal/></person-group><article-title>Comparison of Dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion</article-title><source>Circulation</source><year>2004</year><volume>110</volume><fpage>835</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000138927.00357.FB</pub-id><pub-id pub-id-type="pmid">15289384</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, et al. Comparison of Dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004;110:835&#8211;42. 10.1161/01.CIR.0000138927.00357.FB.<pub-id pub-id-type="pmid">15289384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.CIR.0000138927.00357.FB</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>JC</given-names></name><name name-style="western"><surname>Yun</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Heller</surname><given-names>EN</given-names></name><name name-style="western"><surname>Dione</surname><given-names>DP</given-names></name><name name-style="western"><surname>DeMan</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Limitations of Dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging</article-title><source>J Nucl Med</source><year>1998</year><volume>39</volume><fpage>417</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9529285</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Wu JC, Yun JJ, Heller EN, Dione DP, DeMan P, Liu YH, et al. Limitations of Dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging. J Nucl Med. 1998;39:417&#8211;25.<pub-id pub-id-type="pmid">9529285</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>DW</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JC</given-names></name></person-group><article-title>Gender difference in anaerobic capacity: role of aerobic contribution</article-title><source>Br J Sports Med</source><year>1993</year><volume>27</volume><fpage>45</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/bjsm.27.1.45</pub-id><pub-id pub-id-type="pmid">8457813</pub-id><pub-id pub-id-type="pmcid">PMC1332107</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Hill DW, Smith JC. Gender difference in anaerobic capacity: role of aerobic contribution. Br J Sports Med. 1993;27:45&#8211;8. 10.1136/bjsm.27.1.45.<pub-id pub-id-type="pmid">8457813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjsm.27.1.45</pub-id><pub-id pub-id-type="pmcid">PMC1332107</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorensen</surname><given-names>J</given-names></name><name name-style="western"><surname>Harms</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Aalen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Baron</surname><given-names>T</given-names></name><name name-style="western"><surname>Smiseth</surname><given-names>OA</given-names></name><name name-style="western"><surname>Flachskampf</surname><given-names>FA</given-names></name></person-group><article-title>Myocardial efficiency: A fundamental physiological concept on the verge of clinical impact</article-title><source>JACC Cardiovasc Imaging</source><year>2020</year><volume>13</volume><fpage>1564</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2019.08.030</pub-id><pub-id pub-id-type="pmid">31864979</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Sorensen J, Harms HJ, Aalen JM, Baron T, Smiseth OA, Flachskampf FA. Myocardial efficiency: A fundamental physiological concept on the verge of clinical impact. JACC Cardiovasc Imaging. 2020;13:1564&#8211;76. 10.1016/j.jcmg.2019.08.030.<pub-id pub-id-type="pmid">31864979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2019.08.030</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christianto</surname><given-names>A</given-names></name><name name-style="western"><surname>Baba</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>F</given-names></name><name name-style="western"><surname>Inui</surname><given-names>K</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>M</given-names></name><name name-style="western"><surname>Suyama</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sex differences in metabolic pathways are regulated by Pfkfb3 and Pdk4 expression in rodent muscle</article-title><source>Commun Biol</source><year>2021</year><volume>4</volume><fpage>1264</fpage><pub-id pub-id-type="doi">10.1038/s42003-021-02790-y</pub-id><pub-id pub-id-type="pmid">34737380</pub-id><pub-id pub-id-type="pmcid">PMC8569015</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Christianto A, Baba T, Takahashi F, Inui K, Inoue M, Suyama M, et al. Sex differences in metabolic pathways are regulated by Pfkfb3 and Pdk4 expression in rodent muscle. Commun Biol. 2021;4:1264. 10.1038/s42003-021-02790-y.<pub-id pub-id-type="pmid">34737380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-021-02790-y</pub-id><pub-id pub-id-type="pmcid">PMC8569015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>IG</given-names></name><name name-style="western"><surname>Ranney</surname><given-names>DA</given-names></name></person-group><article-title>Male and female differences in enzyme activities of energy metabolism in Vastus lateralis muscle</article-title><source>J Neurol Sci</source><year>1984</year><volume>65</volume><fpage>323</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/0022-510x(84)90095-9</pub-id><pub-id pub-id-type="pmid">6238135</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Green HJ, Fraser IG, Ranney DA. Male and female differences in enzyme activities of energy metabolism in Vastus lateralis muscle. J Neurol Sci. 1984;65:323&#8211;31. 10.1016/0022-510x(84)90095-9.<pub-id pub-id-type="pmid">6238135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-510x(84)90095-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoshino</surname><given-names>M</given-names></name><name name-style="western"><surname>van de Hoef</surname><given-names>TP</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hamaya</surname><given-names>R</given-names></name><name name-style="western"><surname>Kanaji</surname><given-names>Y</given-names></name><name name-style="western"><surname>Boerhout</surname><given-names>CKM</given-names></name><etal/></person-group><article-title>Abnormal physiological findings after FFR-based revascularisation deferral are associated with worse prognosis in women</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>1027</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-28146-6</pub-id><pub-id pub-id-type="pmid">36658168</pub-id><pub-id pub-id-type="pmcid">PMC9852478</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Hoshino M, van de Hoef TP, Lee JM, Hamaya R, Kanaji Y, Boerhout CKM, et al. Abnormal physiological findings after FFR-based revascularisation deferral are associated with worse prognosis in women. Sci Rep. 2023;13:1027. 10.1038/s41598-023-28146-6.<pub-id pub-id-type="pmid">36658168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-28146-6</pub-id><pub-id pub-id-type="pmcid">PMC9852478</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JM</given-names></name><name name-style="western"><surname>Her</surname><given-names>AY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>CH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Effect of sex difference of coronary microvascular dysfunction on Long-Term outcomes in deferred lesions</article-title><source>JACC Cardiovasc Interventions</source><year>2020</year><volume>13</volume><fpage>1669</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.jcin.2020.04.002</pub-id><pub-id pub-id-type="pmid">32593698</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Chung JH, Lee KE, Lee JM, Her AY, Kim CH, Choi KH, et al. Effect of sex difference of coronary microvascular dysfunction on Long-Term outcomes in deferred lesions. JACC Cardiovasc Interventions. 2020;13:1669&#8211;79. 10.1016/j.jcin.2020.04.002.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcin.2020.04.002</pub-id><pub-id pub-id-type="pmid">32593698</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henning</surname><given-names>RJ</given-names></name></person-group><article-title>The diagnosis and treatment of women with recurrent cardiac ischemia and normal coronary arteries</article-title><source>Curr Probl Cardiol</source><year>2024</year><volume>49</volume><fpage>102124</fpage><pub-id pub-id-type="doi">10.1016/j.cpcardiol.2023.102124</pub-id><pub-id pub-id-type="pmid">37802164</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Henning RJ. The diagnosis and treatment of women with recurrent cardiac ischemia and normal coronary arteries. Curr Probl Cardiol. 2024;49:102124. 10.1016/j.cpcardiol.2023.102124.<pub-id pub-id-type="pmid">37802164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cpcardiol.2023.102124</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gould</surname><given-names>KL</given-names></name><name name-style="western"><surname>Kitkungvan</surname><given-names>D</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>NP</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name><name name-style="western"><surname>Kirkeeide</surname><given-names>R</given-names></name><name name-style="western"><surname>Bui</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mortality prediction by quantitative PET perfusion expressed as coronary flow capacity with and without revascularization</article-title><source>Jacc-Cardiovasc Imag</source><year>2021</year><volume>14</volume><fpage>1020</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2020.08.040</pub-id><pub-id pub-id-type="pmid">33221205</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Gould KL, Kitkungvan D, Johnson NP, Nguyen T, Kirkeeide R, Bui L, et al. Mortality prediction by quantitative PET perfusion expressed as coronary flow capacity with and without revascularization. Jacc-Cardiovasc Imag. 2021;14:1020&#8211;34. 10.1016/j.jcmg.2020.08.040.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2020.08.040</pub-id><pub-id pub-id-type="pmid">33221205</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>